Description

Introducing Coymox-CV Tablets with Lactobacillus: Advanced Antibiotic Support

– Dual-Action Formulation: Each Coymox-CV tablet combines Amoxicillin (500mg) and Clavulanate (125mg) alongside Lactobacillus, offering a balanced approach to antibiotic therapy with added probiotic support.

– Amoxicillin’s Bacterial Control: Amoxicillin targets bacterial cell walls, effectively inhibiting bacterial growth and treating a wide array of infections.

– Clavulanate’s Potentiating Effect: Clavulanate enhances Amoxicillin’s efficacy by inhibiting bacterial resistance mechanisms, ensuring thorough eradication of bacterial infections.

– Probiotic Support: Lactobacillus provides beneficial bacteria to support gastrointestinal health and balance gut flora during antibiotic therapy.

– Versatile Treatment: Coymox-CV tablets are suitable for treating various bacterial infections, including respiratory, urinary tract, and skin infections.

– Scientific Validation: Developed through rigorous research and clinical trials, Coymox-CV tablets ensure both efficacy and safety in antibiotic therapy.

– Convenient Administration: With its tablet form, Coymox-CV simplifies dosing regimens, providing convenient administration for patients while promoting gastrointestinal health.